Correlation Between SynCore Biotechnology and Medigen Biotechnology
Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SynCore Biotechnology Co and Medigen Biotechnology, you can compare the effects of market volatilities on SynCore Biotechnology and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and Medigen Biotechnology.
Diversification Opportunities for SynCore Biotechnology and Medigen Biotechnology
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between SynCore and Medigen is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and Medigen Biotechnology go up and down completely randomly.
Pair Corralation between SynCore Biotechnology and Medigen Biotechnology
Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to generate 1.33 times more return on investment than Medigen Biotechnology. However, SynCore Biotechnology is 1.33 times more volatile than Medigen Biotechnology. It trades about -0.07 of its potential returns per unit of risk. Medigen Biotechnology is currently generating about -0.21 per unit of risk. If you would invest 3,685 in SynCore Biotechnology Co on August 30, 2024 and sell it today you would lose (100.00) from holding SynCore Biotechnology Co or give up 2.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
SynCore Biotechnology Co vs. Medigen Biotechnology
Performance |
| Timeline |
| SynCore Biotechnology |
| Medigen Biotechnology |
SynCore Biotechnology and Medigen Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SynCore Biotechnology and Medigen Biotechnology
The main advantage of trading using opposite SynCore Biotechnology and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.| SynCore Biotechnology vs. Medigen Vaccine Biologics | SynCore Biotechnology vs. OBI Pharma | SynCore Biotechnology vs. TaiMed Biologics | SynCore Biotechnology vs. Adimmune Corp |
| Medigen Biotechnology vs. Sinphar Pharmaceutical Co | Medigen Biotechnology vs. Grape King Bio | Medigen Biotechnology vs. Apex Biotechnology Corp | Medigen Biotechnology vs. Leatec Fine Ceramics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |